An Open-Label, Multicenter, Global Phase 2 Basket Study

Project: Research project

Project Details

Description

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
StatusActive
Effective start/end date9/1/158/31/21

Funding

  • IGNYTA, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.